Hydrogen peroxide prevents vascular calcification induced ROS production by regulating Nrf-2 pathway

References

• Disthabanchong S. Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication. World J Nephrol. 2012;1:43–53.
   PubMedGoogle Scholar
• Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:1241–1248.
   PubMed Web of Science ®Google Scholar
• Schurgers LJ. Vitamin K: Key vitamin in controlling vascular calcification in chronic kidney disease. Kidney Int. 2013;83:782–784.
   PubMed Web of Science ®Google Scholar
• Tbahriti HF, Kaddous A, Bouchenak M, Mekki K. Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients. Biochem Res Int. 2013;2013:358985.
   PubMedGoogle Scholar
• Gutteridge JM, Halliwell B. Antioxidants: Molecules, medicines, and myths. Biochem Biophys Res Commun. 2010;393:561–564.
   PubMed Web of Science ®Google Scholar
• Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83:1029–1041.
   PubMed Web of Science ®Google Scholar
• Disthabanchong S. Lowering vascular calcification burden in chronic kidney disease: Is it possible? World J Nephrol. 2013;2:49–55.
   PubMedGoogle Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–325.
   PubMed Web of Science ®Google Scholar
• Ballanti P, Silvestrini G, Pisano S, et al. Medial artery calcification of uremic patients: A histological, histochemical and ultrastructural study. Histol Histopathol. 2011;26:191–200.
   PubMed Web of Science ®Google Scholar
• Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int. 2014;85:142–150.
   PubMed Web of Science ®Google Scholar
• New SE, Goettsch C, Aikawa M, et al. Macrophage-derived matrix vesicles: An alternative novel mechanism for microcalcification in atherosclerotic plaques. Circulation Res. 2013;113:72–77.
   PubMed Web of Science ®Google Scholar
• Bartnicki P, Fijalkowski P, Majczyk M, Blaszczyk J, Banach M, Rysz J. Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease. Med Sci Monitor. 2013;19:954–959.
   PubMed Web of Science ®Google Scholar
• Xing HY, Cai YQ, Wang XF, et al. The cytoprotective effect of hyperoside against oxidative stress is mediated by the Nrf2-ARE signaling pathway through GSK-3β inactivation. PLoS One. 2015;10:e0145183
   PubMed Web of Science ®Google Scholar
• Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.
   PubMed Web of Science ®Google Scholar
• Byon CH, Javed A, Dai Q, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283:15319–15327.
   PubMed Web of Science ®Google Scholar
• Kannan S, Pang H, Foster DC, Rao Z, Wu M. Human 8-oxoguanine DNA glycosylase increases resistance to hyperoxic cytotoxicity in lung epithelial cells and involvement with altered MAPK activity. Cell Death Different. 2006;13:311–323.
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247.
   PubMed Web of Science ®Google Scholar
• Zucker SN, Fink EE, Bagati A, et al. Nrf2 amplifies oxidative stress via induction of Klf9. Mol Cell. 2014;53:916–928.
   PubMed Web of Science ®Google Scholar
• King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol. 2004;122:333–338.
   PubMed Web of Science ®Google Scholar
• Jeong IK, King GL. New perspectives on diabetic vascular complications: the loss of endogenous protective factors induced by hyperglycemia. Diabetes Metab J. 2011;35:8–11.
   PubMedGoogle Scholar
• Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J. 2012;12:5–18.
   PubMedGoogle Scholar
• Jeong WS, Jun M, Kong AN. Nrf2: A potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 2006;8:99–106.
   PubMed Web of Science ®Google Scholar
• Chapple SJ, Siow RC, Mann GE. Crosstalk between Nrf2 and the proteasome: Therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol. 2012;44:1315–1320.
   PubMed Web of Science ®Google Scholar
• Giudice A, Arra C, Turco MC. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol. 2010;647:37–74.
   PubMedGoogle Scholar
• Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76–86.
   PubMed Web of Science ®Google Scholar
• Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: Keep one eye beyond Keap1. Cancer Lett. 2006;233:208–218.
   PubMed Web of Science ®Google Scholar
• Pan H, He M, Liu R, Brecha NC, Yu AC, Pu M. Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway. PLoS One. 2014;9:e114186.
   PubMed Web of Science ®Google Scholar
• Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, Yoneda Y. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem. 2006;281:18015–18024.
   PubMed Web of Science ®Google Scholar
• Liu H, Lu Q, Huang K. Selenium suppressed hydrogen peroxide-induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation. J Cell Biochem. 2010;111:1556–1564.
   PubMed Web of Science ®Google Scholar